Cargando…

Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity

Preclinical in vitro models provide an essential tool to study cancer cell biology as well as aid in translational research, including drug target identification and drug discovery efforts. For any model to be clinically relevant, it needs to recapitulate the biology and cell heterogeneity of the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correa, Bruna R. S., Hu, Joanna, Penalva, Luiz O. F., Schlegel, Richard, Rimm, David L., Galante, Pedro A. F., Agarwal, Seema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840339/ https://www.ncbi.nlm.nih.gov/pubmed/29511269 http://dx.doi.org/10.1038/s41598-018-22427-1

Ejemplares similares

Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma
por: Correa, Bruna R., et al.
Publicado: (2016)

Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo
por: Krawczyk, Ewa, et al.
Publicado: (2019)

Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks
por: Palechor-Ceron, Nancy, et al.
Publicado: (2019)

Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles
por: Guardia, Gabriela D. A., et al.
Publicado: (2020)

Conditional cell reprogramming involves non-canonical β-catenin activation and mTOR-mediated inactivation of Akt
por: Suprynowicz, Frank A., et al.
Publicado: (2017)

Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization
por: Rajan, Sanjana, et al.
Publicado: (2023)

Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development
por: Velasco, Mitzli X., et al.
Publicado: (2019)

β-arrestin-1 suppresses myogenic reprogramming of brown fat to maintain euglycemia
por: Pydi, Sai P., et al.
Publicado: (2020)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019)

Conditionally reprogrammed primary airway epithelial cells maintain morphology, lineage and disease specific functional characteristics
por: Martinovich, Kelly M., et al.
Publicado: (2017)

Intra-tumor Genetic Heterogeneity in Rectal Cancer
por: Hardiman, Karin M., et al.
Publicado: (2015)

Phylogenetic Quantification of Intra-tumour Heterogeneity
por: Schwarz, Roland F., et al.
Publicado: (2014)

Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts
por: Kemper, Kristel, et al.
Publicado: (2015)

Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research
por: Daneshdoust, Danyal, et al.
Publicado: (2023)

Generation of stable PDX derived cell lines using conditional reprogramming
por: Borodovsky, Alexandra, et al.
Publicado: (2017)

Tissue-specific reprogramming of glutamine metabolism maintains tolerance to sepsis
por: Leitner, Brooks P., et al.
Publicado: (2023)

Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer
por: Jones, Huw Geraint, et al.
Publicado: (2017)

Synergism of Proneurogenic miRNAs Provides a More Effective Strategy to Target Glioma Stem Cells
por: Kosti, Adam, et al.
Publicado: (2021)

Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer
por: Cooke, S L, et al.
Publicado: (2011)

Metabolic reprogramming heterogeneity in chronic kidney disease
por: Miguel, Verónica, et al.
Publicado: (2023)

Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons
por: Tang, Yu, et al.
Publicado: (2017)

Multifactorial Analysis of Conditional Reprogramming of Human Keratinocytes
por: Ligaba, Segni B., et al.
Publicado: (2015)

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
por: Ng, Charlotte KY, et al.
Publicado: (2015)

The RNA-Binding Protein Musashi1 Regulates a Network of Cell Cycle Genes in Group 4 Medulloblastoma
por: Baroni, Mirella, et al.
Publicado: (2021)

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma
por: López-Carrasco, Amparo, et al.
Publicado: (2021)

Breast cancer intra-tumor heterogeneity
por: Martelotto, Luciano G, et al.
Publicado: (2014)

Collaborative intra-tumor heterogeneity detection
por: Khakabimamaghani, Sahand, et al.
Publicado: (2019)

Ground-State Conditions Promote Robust Prdm14 Reactivation and Maintain an Active Dlk1-Dio3 Region during Reprogramming
por: Habib, Omer, et al.
Publicado: (2014)

Hypoxia-induced reprogramming of glucose-dependent metabolic pathways maintains the stemness of human bone marrow-derived endothelial progenitor cells
por: Lin, Dongni, et al.
Publicado: (2023)

SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state
por: Hsu, Jessica Y., et al.
Publicado: (2022)

SMITH: spatially constrained stochastic model for simulation of intra-tumour heterogeneity
por: Streck, Adam, et al.
Publicado: (2023)

Heterogeneity of Osteosarcoma Cell Lines Led to Variable Responses in Reprogramming
por: Choong, Pei Feng, et al.
Publicado: (2014)

Region-Restrict Astrocytes Exhibit Heterogeneous Susceptibility to Neuronal Reprogramming
por: Hu, Xin, et al.
Publicado: (2019)

Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development
por: Sobral, Daniel, et al.
Publicado: (2022)

Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer
por: Timofeeva, Olga A., et al.
Publicado: (2016)

Intra-Tumor Heterogeneity Revealed by Mass Spectrometry Imaging Is Associated with the Prognosis of Breast Cancer
por: Gawin, Marta, et al.
Publicado: (2021)

Overview on Clinical Relevance of Intra-Tumor Heterogeneity
por: Stanta, Giorgio, et al.
Publicado: (2018)

Addressing intra-tumoral heterogeneity and therapy resistance
por: Rybinski, Brad, et al.
Publicado: (2016)

Conditionally Reprogrammed Normal and Transformed Mouse Mammary Epithelial Cells Display a Progenitor-Cell–Like Phenotype
por: Saenz, Francisco R., et al.
Publicado: (2014)

Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development
por: Ci, Xinpei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dgh1pa2s1i0dmdgi16l0eu2gbk